The Gross Margin of BrightPath Biotherapeutics Co Ltd (4594.T) is 97.18%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-03-31 | 97.18% |
| 2024-03-31 | 75.00% |
| 2023-03-31 | 64.11% |
| 2022-03-31 | 78.47% |
| 2021-03-31 | 54.27% |
| 2020-03-31 | 60.47% |
| 2019-03-31 | 54.62% |
| 2018-03-31 | 11.07% |
| 2017-03-31 | 0.89% |
| 2016-03-31 | 6.19% |